Cargando…

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation

Detalles Bibliográficos
Autores principales:	Christopoulos, Petros, Gaipl, Udo S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106749/ https://www.ncbi.nlm.nih.gov/pubmed/37077834 http://dx.doi.org/10.3389/fonc.2023.1182081

Ejemplares similares

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
por: Yang, Ruoning, et al.
Publicado: (2022)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
por: Wang, Yusha, et al.
Publicado: (2023)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Frontiers Research Topic: Radiation-Induced Effects and the Immune System
por: Multhoff, Gabriele, et al.
Publicado: (2013)

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches
por: van de Donk, Niels W. C. J., et al.
Publicado: (2020)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
por: Reichle, Albrecht, et al.
Publicado: (2020)

Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives
por: Lumniczky, Katalin, et al.
Publicado: (2018)

Editorial to Radiation in Multimodal Tumor Immune Therapies—Mechanisms and Application
por: Frey, Benjamin, et al.
Publicado: (2021)

Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
por: Deloch, Lisa, et al.
Publicado: (2016)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling
por: Paggetti, Jérôme, et al.
Publicado: (2021)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

Editorial: Translational research in the diagnosis and development of therapeutics for peritoneal surface malignancies
por: Chia, Claramae Shulyn, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
por: Liu, Yao, et al.
Publicado: (2022)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches
por: Tarallo, M., et al.
Publicado: (2023)

Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma
por: De Martino, Mara, et al.
Publicado: (2021)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
por: Rubner, Yvonne, et al.
Publicado: (2012)

Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
por: Vander Linden, Catherine, et al.
Publicado: (2019)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles
por: Mondal, Deepankar, et al.
Publicado: (2023)

Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer
por: Burotto, Mauricio, et al.
Publicado: (2014)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells
por: Gehre, Simon, et al.
Publicado: (2023)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Prognostic and Predictive Biomarkers and Therapy
por: Moussay, Etienne, et al.
Publicado: (2022)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
por: Chao, Mark P., et al.
Publicado: (2020)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Editorial: The role of imaging in gynecological malignancies
por: Han, Kathy, et al.
Publicado: (2023)

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
por: Datta, Niloy R., et al.
Publicado: (2020)

Immunomodulatory Properties and Molecular Effects in Inflammatory Diseases of Low-Dose X-Irradiation
por: Rödel, Franz, et al.
Publicado: (2012)

Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents
por: Daniotti, Jose Luis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g1trurq5f9cklu0sehbh6lj0n8